Journal of Drugs in Dermatology - Efalizumab for severe atopic dermatitis
Journal of Drugs in Dermatology - Efalizumab for severe atopic dermatitis
May 1, 2007 -- A recent study demonstrated that efalizumab may be a potential treatment for recalcitrant atopic eczema. The safety and efficacy of efalizumab was...
Click Here to read the entire article...
more atopic dermatitis articles...
>> |
|
|
What is atopic dermatitis?
It is a chronic inflammatory disease of the skin manifested by increased ability to form immunoglobulin E (allergic antibodies), increasing vulnerability to asthma and allergic rhinitis and hereditary nature to a lowered entry of protein. The skin is marked by red, thick, swelling, watery skin resulting from constant rubbing and scratching, excoriation and crusting mainly on surfaces of the elbow and knee. It is called infantile eczema in infants.
|
|
